FOLOTYN

Related by string. Folotyn * * FOLOTYN ® . administering FOLOTYN . FOLOTYN folate analogue *

Related by context. All words. (Click for frequent words.) 74 pralatrexate 71 blinatumomab 70 perifosine 69 picoplatin 69 VELCADE 69 Amrubicin 68 Clolar 68 albinterferon alfa 2b 68 relapsed multiple myeloma 68 vandetanib 68 sapacitabine 68 ofatumumab 68 forodesine 68 FOLOTYN ® 68 satraplatin 67 Dacogen injection 67 glufosfamide 67 refractory Hodgkin lymphoma 67 XL# [003] 67 PROMACTA 67 HuMax CD4 67 SUTENT 67 alvespimycin 67 teduglutide 67 oral ridaforolimus 67 lintuzumab 66 HGS ETR1 66 LymphoStat B 66 Tamibarotene 66 CoFactor 66 Vectibix 66 ZEVALIN 66 Fludara 66 valopicitabine 66 eltrombopag 66 elotuzumab 66 Folotyn 66 ERBITUX 66 Genasense 66 deforolimus 66 ganetespib 66 MOZOBIL 66 eniluracil 66 ONTAK 66 INCB# [002] 66 tesetaxel 66 clofarabine 66 ularitide 66 TELCYTA 66 AGGRASTAT ® 65 OPAXIO 65 talactoferrin 65 MGCD# [001] 65 ezogabine 65 PXD# 65 VPRIV 65 Clolar ® 65 Insegia 65 Dacogen 65 romiplostim 65 L BLP# 65 TYKERB 65 Ventavis 65 Raptiva ® 65 amrubicin 65 AGGRASTAT R 65 BEXXAR 65 IMGN# 65 metastatic colorectal cancer 65 AP# [003] 65 panitumumab 65 registrational 65 belinostat 65 carfilzomib 65 decitabine 65 Tavocept 65 ponatinib 65 Marqibo 65 Genasense ® 65 CYCLOSET 65 KALBITOR 65 refractory PTCL 65 Amigal 65 ADVEXIN 65 ridaforolimus 64 TORISEL 64 Vidaza 64 Zelrix 64 sunitinib malate 64 Azedra 64 axitinib 64 BENLYSTA 64 RG# [001] 64 Azixa 64 EOquin TM 64 OvaRex ® MAb 64 YERVOY 64 eculizumab 64 phase IIb clinical 64 enzastaurin 64 TRISENOX 64 IRESSA 64 CR# vcMMAE 64 dirucotide 64 PROVENGE 64 RITUXAN 64 mRCC 64 Taxotere R 64 Ceplene 64 tamibarotene 64 LEUKINE 64 obatoclax 64 Ceflatonin 64 HRPC 64 AVASTIN 64 YONDELIS 64 Evoltra 64 Increlex R 64 ambrisentan 64 EFAPROXYN 64 Feraheme 64 Civacir 63 Afinitor 63 brentuximab vedotin 63 ZYBRESTAT 63 BARACLUDE R 63 Jevtana 63 tanespimycin 63 voreloxin 63 Traficet EN 63 Nexavar ® 63 PREOS 63 Zerenex 63 metastatic CRC 63 ELACYT 63 L MTP PE 63 JAK inhibitor 63 Phase 2b trial 63 aflibercept 63 Phenoptin 63 dacetuzumab 63 relapsed refractory multiple myeloma 63 BAY #-# 63 GATTEX 63 fidaxomicin 63 alvimopan 63 NUVIGIL 63 Cloretazine 63 OLEPTRO TM 63 vosaroxin 63 sorafenib tablets 63 Taxotere ® 63 HER2 positive metastatic breast 63 azacitidine 63 Plenaxis R 63 OncoVEX GM CSF 63 ZOLINZA 63 TREANDA 63 VIDAZA 63 Increlex ® 63 bendamustine 63 maribavir 63 EOquin 63 Troxatyl 63 ORENCIA R 63 Phase 2b study 63 REVLIMID 63 TYSABRI 63 pegloticase 63 monotherapy 63 Amitiza 63 Panzem R NCD 63 Cloretazine R VNP#M 63 TELINTRA 63 Campath 63 MyVax R 63 ixabepilone 63 FavId 63 Tarceva 63 Tarceva TM 63 Plenaxis TM 63 pertuzumab 63 Fibrillex TM 63 Leukine 63 Nexavar 63 Neulasta ® 63 ISENTRESS 63 DAVANAT R 63 metastatic renal cell carcinoma 62 cutaneous T cell 62 otelixizumab 62 elacytarabine 62 SNT MC# 62 rNAPc2 62 Cimzia ® 62 ThermoDox ® 62 omacetaxine 62 bazedoxifene 62 Certican 62 Pirfenidone 62 atacicept 62 pegfilgrastim 62 MabCampath 62 TOCOSOL Paclitaxel 62 pomalidomide 62 Cinryze TM 62 registrational trial 62 Defibrotide 62 SEROQUEL 62 Raptiva R 62 phase IIb trial 62 methylnaltrexone 62 PROVIGIL 62 Allovectin 7 62 daclizumab 62 PEG SN# 62 Azilect ® 62 INCB# [001] 62 Pralatrexate 62 Evoltra ® 62 celgosivir 62 AZILECT ® 62 OXi# 62 telbivudine 62 refractory multiple myeloma 62 PhosLo 62 INTEGRILIN 62 chronic angina 62 Phase Ib 62 Ixempra 62 LEVADEX ™ 62 huC# DM4 62 tesmilifene 62 ABRAXANE 62 Aurexis 62 Targretin 62 Chemophase 62 lubiprostone 62 Icatibant 62 Virulizin R 62 tivozanib 62 AzaSite 62 Phase Ib study 62 BENLYSTA ® 62 SPRYCEL 62 Bezielle 62 ACTEMRA 62 ENTEREG 62 REOLYSIN ® 62 custirsen 62 REVLIMID R 62 hormone refractory prostate cancer 62 EDEMA3 62 TYZEKA 62 Evoltra TM 62 EGFR expressing mCRC 62 Æterna Zentaris 62 THALOMID 62 romidepsin 62 elagolix 62 prGCD 62 ruxolitinib 62 pixantrone 62 oral deforolimus 62 Mylotarg 62 Catena ® 62 ecallantide 61 PEG INTRON 61 Personalized Immunotherapy 61 Restanza 61 Neuradiab 61 XGEVA 61 Proxinium TM 61 BRIM2 61 vidofludimus 61 galiximab 61 INC# 61 PEG Interferon lambda 61 AQ4N 61 Hepatocellular Carcinoma HCC 61 Combidex 61 CANCIDAS 61 Gemzar ® 61 Targretin capsules 61 confirmatory Phase III 61 ThermoDox R 61 neratinib 61 Cimzia TM 61 Bicifadine 61 AMPYRA 61 T DM1 61 TEMODAL 61 R sorafenib tablets 61 darapladib 61 KRN# 61 SILENOR TM 61 Nplate 61 Entereg 61 RECOTHROM 61 ZACTIMA 61 Asentar 61 pirfenidone 61 lumiliximab 61 RSD# 61 Prestara 61 REPLAGAL 61 ZADAXIN 61 Phase 2a trial 61 nimotuzumab 61 Cellegesic 61 ASA# 61 B CLL 61 TOLAMBA 61 VAPRISOL 61 ozarelix 61 OMAPRO 61 Allovectin 7 ® 61 Prochymal 61 vernakalant oral 61 Treanda 61 Hematide 61 Phase 1b trial 61 cancer neuroendocrine tumor 61 vemurafenib 61 metastatic GIST 61 PRISTIQ 61 SinuNase 61 MYDICAR 61 pradefovir 61 RIGScan CR 61 vilazodone 61 ALN RSV# 61 UPLYSO 61 NPSP# 61 imetelstat 61 TNFerade 61 HGS ETR2 61 BiovaxID 61 FUSILEV 61 refractory CTCL 61 STELARA 61 Firazyr 61 PDX pralatrexate 61 oral methylnaltrexone 61 Ganite R 61 ZENPEP 61 interferon gamma 1b 61 refractory metastatic colorectal cancer 61 Avastin bevacizumab 61 Tarceva erlotinib 61 MNTX 61 Ranexa 61 PREZISTA r 61 peginesatide 61 ACTEMRA TM 61 refractory acute myeloid 61 PHX# 61 indolent NHL 61 ATryn R 61 mCRC 61 FACTIVE 61 Cinryze ™ 61 cilengitide 61 NOXAFIL 61 Cinryze 61 vinorelbine 61 plus dexamethasone 61 biologic therapy 61 castration resistant prostate cancer 61 ARIKACE 61 cetrorelix 61 NEBIDO 61 PREOS R 61 Plicera 61 AEGR 61 Voraxaze ™ 61 Allovectin 7 R 61 NEUPOGEN 61 adalimumab 61 ZEGERID Powder 61 MAA submission 61 Virulizin ® 61 PRT# 61 AVONEX 60 HGS# 60 APOPTONE 60 HERmark 60 docetaxel 60 Phase IIIb clinical 60 ONCASPAR 60 Fodosine 60 Zirgan 60 ARCALYST 60 refractory chronic lymphocytic 60 Abraxane 60 lymphoma CTCL 60 CAELYX 60 pralatrexate injection 60 FIRAZYR 60 Vandetanib 60 AZILECT R 60 nitazoxanide 60 PLK1 SNALP 60 UVIDEM 60 pemetrexed 60 DAVANAT 60 denufosol 60 Gleevec Glivec 60 SPRYCEL ® 60 mipomersen 60 Increlex 60 RAPTIVA 60 Intermezzo R 60 HCD# [002] 60 regorafenib 60 PF # [001] 60 HUMIRA 60 Kuvan 60 SANVAR 60 Trastuzumab 60 Aloxi 60 MAGE A3 ASCI 60 sunitinib 60 Torisel 60 Actimmune ® 60 trabectedin 60 advanced NSCLC 60 Cethrin 60 #D#C# 60 Phase 1b 60 bevacizumab Avastin 60 Corlux 60 Naglazyme 60 Campath ® 60 Canvaxin 60 Pixuvri 60 Archexin 60 Ceflatonin R 60 trastuzumab DM1 T DM1 60 cell lymphoma CTCL 60 IV APAP 60 JANUVIA 60 velaglucerase alfa 60 PEGINTRON 60 thymalfasin 60 bardoxolone 60 phase IIa clinical 60 Canvaxin TM 60 platinum refractory 60 Cimzia R 60 taribavirin 60 pivotal Phase III 60 Stimuvax 60 HuMax EGFr 60 Rescula 60 Perifosine 60 dacarbazine 60 MYDICAR ® 60 CD# antibody [001] 60 Golimumab 60 goserelin 60 REMICADE ® 60 PrevOnco 60 torezolid phosphate 60 ALIMTA 60 entinostat 60 phase Ib 60 velafermin 60 dimebon 60 IPLEX 60 SAPHRIS 60 Phase IIb clinical 60 Mycamine 60 cetuximab Erbitux 60 vismodegib 60 relapsed SCLC 60 Entereg R 60 AMEVIVE 60 Vectibix panitumumab 60 Cotara 60 Cladribine Tablets 60 GAMMAGARD 60 zileuton 60 sipuleucel T 60 ASONEP 60 REVLIMID lenalidomide 60 Alzhemed TM 60 orBec R 60 dose cohort 60 ZOSTAVAX 60 Alemtuzumab 60 Orapred ODT 60 retigabine 60 Phase 2b clinical 60 ZEGERID Capsules 60 Arzerra 60 gastrointestinal stromal tumor GIST 60 gefitinib 60 plus gemcitabine 60 CIMZIA TM 60 Bronchitol 60 SYCREST 60 refractory gout 60 Locteron 60 sorafenib 60 Vimpat ® 60 cinacalcet HCl 60 HuLuc# 60 RSR# 60 MEPACT 60 DR Cysteamine 60 Nuvion 60 PegIntron 60 rhThrombin 60 temozolomide 60 Nabi HB Intravenous 60 ATryn ® 60 non metastatic osteosarcoma 60 BRIM3 60 mCRC patients 60 Velcade bortezomib 60 Nexavar prescribing 60 TYGACIL 60 receptor tyrosine kinase inhibitor 60 ZYFLO 60 BioNumerik 60 Revlimid lenalidomide 60 Actemra 60 MYLOTARG 60 Omigard 60 rilonacept 60 terlipressin 60 ISTODAX 60 Soliris TM eculizumab 60 infusional 5-FU/LV 60 Amplimexon 60 Angiomax 60 Annamycin 60 Phase Ib II 60 LHRH antagonist 60 APPRAISE 60 herpetic keratitis 60 evaluating Xcytrin 60 MBP# [001] 60 AzaSite Plus 60 rindopepimut 60 BROVANA 60 SUPPRELIN R LA 60 HspE7 60 subcutaneous formulation 60 phase IIb 60 SIMPONI 60 RSD# iv 60 bevacizumab Avastin ® 59 Nanobody 59 oxymorphone ER 59 XIBROM 59 lorvotuzumab mertansine 59 SUCCEED trial 59 Sym# 59 ORENCIA ® 59 Onco TCS 59 nab paclitaxel 59 ITAX 59 HuMax CD# 59 posaconazole 59 LIALDA 59 CIMZIA ™ 59 Zevalin 59 apaziquone 59 SEROQUEL XR 59 leading oral taxane 59 investigational compound 59 Pemetrexed 59 INTELENCE 59 Lumacan 59 clevudine 59 metastatic castration resistant 59 Xanafide 59 ospemifene 59 DOXIL 59 Sebivo 59 refractory APL 59 Triolex 59 CA4P 59 GATTEX TM 59 Vasovist 59 palifosfamide 59 multiple myeloma MM 59 zanolimumab 59 XIAFLEX 59 Urocidin 59 MERLIN TIMI 59 Xcytrin R 59 unique alkylating agent 59 Aplidin 59 chronic hepatitis C. 59 erlotinib 59 efalizumab 59 Keppra ® 59 PROVENGE ® 59 Androxal 59 FASLODEX 59 TASQ 59 pharmacokinetic PK study 59 COMFORT II 59 adult chronic ITP 59 rFIXFc 59 sorafenib Nexavar 59 taliglucerase alfa 59 ruboxistaurin 59 randomized Phase 59 alemtuzumab 59 Multaq R 59 aflibercept VEGF Trap 59 OMNARIS Nasal Spray 59 dose cohorts 59 lapatinib Tykerb 59 NEUMUNE 59 sorafenib Nexavar ® 59 FUZEON 59 Vaprisol 59 Rhucin ® 59 mapatumumab 59 EndoTAG TM -1 59 castrate resistant prostate cancer 59 CUBICIN 59 PANVAC VF 59 AEG# 59 ROTATEQ 59 Q#IR 59 Clavis Pharma 59 IV Busulfex 59 epratuzumab 59 lesinurad 59 Neurodex 59 SYMMETRY trial 59 Fampridine SR 59 XYOTAX 59 Viramidine 59 tafamidis 59 Strativa 59 ZETIA 59 RAPTIVA R 59 assessing T DM1 59 docetaxel Taxotere ® 59 rALLy trial 59 PROCHIEVE 8 59 Ganite ® 59 linaclotide 59 ATL# [001] 59 Aptivus 59 Zenvia 59 GRN#L 59 Rhucin 59 Actimmune R 59 Rebif ® 59 Soliris 59 Reolysin 59 ARIXTRA 59 JANUMET 59 DASISION 59 Oncophage 59 BrachySil TM 59 rasagiline tablets 59 JOULFERON 59 ENBREL 59 SAR# [004] 59 abatacept 59 Macugen 59 vernakalant 59 Halaven 59 anti angiogenic therapy 59 QUADRAMET 59 INTERCEPT platelets 59 IoGen 59 ZYVOX 59 LibiGel Phase III 59 regadenoson 59 bicifadine 59 REVLIMID ® 59 LibiGel ® 59 Fx #A 59 Satraplatin 59 dose escalation trial 59 FTY# 59 IMiDs 59 Benlysta belimumab 59 Loramyc R 59 DIFICID 59 PI3K/Akt pathway inhibitor 59 Ceflatonin ® 59 ocrelizumab 59 Advagraf 59 randomized Phase III 59 Revimmune 59 eritoran 59 APRISO 59 tecarfarin 59 CYT# 59 metastatic HRPC 59 Angiox R 59 XmAb# 59 NP2 Enkephalin 59 Loramyc ® 59 mertansine 59 pain palliation 59 TRANSDUR Sufentanil 59 investigational monoclonal antibody 59 FUSILEV ® 59 FROVA 59 Apoptone 59 ThermoDox 59 pivotal Phase 59 gefitinib Iressa 59 Pentacel vaccine 59 radiation sensitizer 59 dirucotide MBP# 59 APTIVUS r 59 Mozobil 59 nilotinib 59 docetaxel chemotherapy 59 TRISENOX ® 59 Advexin 59 Tracleer R 59 palonosetron 59 Hepsera 59 fluoropyrimidine 59 ELADUR 59 POSIDUR 59 reslizumab 59 Zalbin 59 TheraCIM 59 IIa trial 59 ZEVALIN ® 59 veltuzumab 59 oxypurinol 59 EGRIFTA TM 59 Elidel 59 heavily pretreated 59 Dabigatran etexilate 59 rALLy clinical trial 59 telaprevir 59 Octreolin 59 motavizumab 58 Veronate 58 Xigris 58 pazopanib 58 tocilizumab 58 NeuroStar TMS Therapy 58 Phase III clinical 58 IL# PE#QQR 58 IRX 2 58 pseudobulbar affect PBA 58 ZADAXIN ® 58 recurrent NSCLC 58 ranolazine 58 KNS # 58 Ophena TM 58 Zolinza 58 AVE# 58 Aflibercept 58 Junovan 58 Exalgo 58 VELCADE melphalan 58 Zavesca r 58 Betaferon ® 58 anticancer compound 58 placebo controlled clinical 58 telavancin 58 GATTEX ® 58 trastuzumab DM1 58 dabigatran etexilate 58 hematologic malignancies 58 PEG PAL 58 Kepivance 58 elesclomol 58 Elotuzumab 58 MGCD# [002] 58 ABILIFY R 58 ipilimumab 58 ToGA 58 oncology indications 58 IMA# 58 octreotide implant 58 DEFINITY ® 58 Vivaglobin 58 metastatic melanoma 58 FOLFIRI 58 silodosin 58 EGFR inhibitors 58 Acetavance 58 ZALBIN 58 MACUGEN 58 Thalomid ® 58 SCH # 58 Quinamed 58 rFVIIIFc 58 ONSOLIS 58 tolerated dose MTD 58 indiplon capsules 58 Indaflex TM 58 edoxaban 58 golimumab 58 lupus nephritis 58 temsirolimus 58 cangrelor 58 Ambrisentan 58 voclosporin 58 ENTEREG ® 58 dasatinib Sprycel ® 58 Cetrorelix 58 IMC A# 58 PROCRIT 58 Elagolix 58 MAP# 58 Rituximab 58 Phase IIb trial 58 NGX# 58 Feraheme ® 58 Surfaxin LS 58 Xyrem ® 58 metastatic hormone refractory 58 Clonicel 58 CBLC# 58 Hycamtin 58 Cleviprex TM clevidipine 58 XL# XL# 58 MoxDuo IR 58 secondary efficacy endpoints 58 Frova R 58 investigational immunotherapy 58 relapsing multiple sclerosis 58 gastrointestinal stromal tumors GIST 58 OHR/AVR# 58 Angiox 58 Fludara ® 58 pediatric Crohn disease 58 lurasidone 58 BiTE antibody 58 MultiStem 58 Aclasta 58 ADAGIO study 58 Atiprimod 58 Onrigin 58 Omnitarg 58 randomized Phase 2b 58 Degarelix 58 LEVADEX 58 opioid induced bowel dysfunction 58 refractory peripheral T 58 BENICAR HCT 58 Femara 58 alefacept 58 Everolimus 58 TG# [003] 58 OvaRex R 58 Tocosol Paclitaxel 58 DU #b 58 pitavastatin 58 Marketing Authorization Application 58 NATRECOR R 58 Neupogen ® 58 surrogate endpoint 58 ABILIFY ® 58 Herceptin trastuzumab 58 antiepileptic drug 58 Perforomist ™ Inhalation Solution 58 Numax 58 StemEx R 58 TTF Therapy 58 Myocet 58 Rhucin R 58 OMNARIS HFA 58 docetaxel Taxotere R 58 Vectibix monotherapy 58 Chrysalin 58 tipranavir 58 Nabi HB 58 LUCENTIS 58 Diamyd ® 58 bevacizumab 58 candidate epratuzumab 58 RoACTEMRA 58 Omigard TM 58 pediatric acute lymphoblastic 58 Zavesca R 58 Sulonex TM 58 danoprevir 58 pancreatic neuroendocrine tumors 58 Xcytrin 58 dasatinib 58 Nexavar sorafenib 58 metaglidasen 58 ISIS # 58 C1 INH 58 PROPEL trial 58 CTAP# Capsules 58 Allos retains exclusive 58 tramiprosate ALZHEMED TM 58 Sycrest 58 Phase IIb trials 58 Phase III HEAT 58 MabThera Rituxan 58 Soriatane 58 AMITIZA 58 biliary tract cancer 58 KAPVAY ™ 58 Mipomersen 58 non squamous NSCLC 58 SinuNase TM 58 Urocidin TM 58 MAXY G# 58 Genasense R 58 relapsed MM 58 MDV# 58 thalidomide Thalomid 58 anti leukemic 58 ZYFLO CR 58 omacetaxine mepesuccinate 58 refractory angina 58 iloperidone 58 AZD# 58 Telavancin 58 TroVax 58 recurrent ovarian cancer 58 GED aPC 58 Desmoteplase 58 Nimotuzumab 58 Pazopanib 58 anakinra 58 Pegasys ® 58 ARIMIDEX 58 brentuximab vedotin SGN 58 Inhalation Solution 58 MGd 58 RhuDex ® 58 angiogenesis inhibitor 58 Fablyn 58 Symadex 58 randomized Phase IIb 58 cintredekin besudotox 58 ONGLYZA 58 teriflunomide 58 Promacta 58 Carfilzomib 58 APF# 58 Bortezomib 58 POSIDUR TM 58 sBLA 58 Alpharadin 58 vicriviroc 58 Cx# [002] 58 Phase 1b clinical 58 FACTIVE R gemifloxacin 58 Tekamlo 58 relapsing remitting multiple sclerosis 58 Aloxi injection 58 cetuximab Erbitux ® 58 muraglitazar 58 dose escalation 58 CCX# 58 diabetic neuropathic pain 58 Arixtra 58 oral Xeloda 58 FACTIVE tablets 58 paliperidone ER 58 recurrent GBM 58 Clevudine 58 DepoBupivacaine TM 58 Unit Dose Budesonide 58 CytoFab 58 Aromasin 58 GALNS 58 clevidipine 58 ProLindac 58 BCX# 58 CD3 monoclonal antibody 58 MEK inhibitors 57 Emselex 57 virus HCV protease inhibitor 57 evaluating tivozanib 57 Besivance 57 asenapine 57 Ranexa R 57 Dapagliflozin 57 ongoing Phase 1b 57 hormone LHRH antagonist 57 GTC recombinant human 57 investigational therapies 57 brivaracetam 57 mycophenolate mofetil 57 KRAS status 57 CellCept 57 hematological malignancies 57 adecatumumab 57 ofatumumab HuMax CD# 57 Keppra R 57 vorinostat

Back to home page